[RESEARCH ON THE ANTIFIBRILLATORY ACTION OF 3,3-DIPHENYL-N-(ALPHA-METHYLPHENETHYL)-3-PROPYLAMINE (SEGONTIN)].
D031841:Aconitum; D001713:Biphenyl Compounds; D002415:Cats; D004071:Digitalis Glycosides; D055724:Electrophysiological Phenomena; D004594:Electrophysiology; D006168:Guinea Pigs; D006321:Heart; D010600:Pharmacology; D011299:Prenylamine; D011437:Propylamines; D011802:Quinidine; D012106:Research; D013328:Strophanthins; D014116:Toxicology; D014693:Ventricular Fibrillation
D001713:Biphenyl Compounds; D004071:Digitalis Glycosides; D011299:Prenylamine; D011437:Propylamines; D011802:Quinidine; D013328:Strophanthins; C010574:biphenyl
ACONITE; CATS; DIGITALIS GLYCOSIDES; ELECTROPHYSIOLOGY; EXPERIMENTAL LAB STUDY; GUINEA PIGS; HEART; PHARMACOLOGY; PRENYLAMINE; QUINIDINE; STROPHANTHIN; TOXICOLOGIC REPORT; VENTRICULAR FIBRILLATION
UNTERSUCHUNGEN UEBER DIE FLIMMERWIDRIGE WIRKUNG DES N-(3'-PHENYL-PROPYL-(2'))-1,1-DIPHENYLPROPYL-(3)-AMINS (SEGONTIN)